OnTarget Molecules

OnTarget Molecules is an early-stage drug discovery company based in San Diego, California, that focuses on the design and development of novel small molecule therapeutics. The company leverages deep expertise in medicinal chemistry and synthetic organic chemistry to address challenging biological targets in oncology and neurodegenerative disorders. Founded by veteran pharmaceutical researchers, OnTarget Molecules aims to identify and optimize lead compounds with high selectivity and improved safety profiles. Its current efforts are centered on building a robust internal pipeline of candidates in the pre-clinical and discovery stages. The company operates as a private entity, prioritizing research into high-value therapeutic areas where there is significant unmet medical need.